Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by CreatingApeon Oct 14, 2024 10:11am
84 Views
Post# 36265117

RE:RE:Tesamorelin

RE:RE:TesamorelinYes sure, SPCEO had mentioned it being used by a very niche body building community years ago.   Now we have two Dr's on a podcast with over 6 MILLION subscribers talking about it. How many people listening to this science podcast are willing to inject something off of the black market into themselves? 

Did you know that more than half of the prescriptions in the U.S are prescribed for off label uses? That's exactly what is happening right now for us and tesamorelin. This isn't some obscure article in a medical journal read by a thousand people. This is a world renowned podcast listened to by millions of people and tens of thousands of medical professionals. I don't think you understand how vast and influential Dr. Hubermans podcast is... 

Tesamorelin in going main stream. 
<< Previous
Bullboard Posts
Next >>